ObjectiveThe reduction in the level of mental health, particularly depression is associated with outcome of treatment in patients with osteoarthritis (OA). There is no broader research into mental health or mental health care for OA patients. The purpose of the present study was to determine mental health and its relationship with some clinical and demographic factors among patients with OA.Material and methods94 patients with osteoarthritis were included in presented study. Patients were referred to hospital during the year of 2016, 30 male patients (31.9%) and 64 female (68.1%), female/male ratio was about 2 : 1. All patients were evaluated in the term of mental health through demographic questionnaire and SCL-90R questionnaire and the obtained data were analyzed using version 22 of SPSS Software.ResultsThe results showed that 58.5% of patients with osteoarthritis had mental health disorders. Among all studied patients mental health disorders were found in 55 patients (58.5%), including both isolated and complex disorders such as: psychological discomfort in the form of somatic symptoms disorder (n = 45), obsessive compulsive disorders (n = 43), interpersonal sensitivity (n = 44), depression (n = 47), anxiety (n = 41), aggression (n = 52), phobia (n = 42), paranoid psychosis (n = 32), psychosis (n = 3). In addition, the prevalence of mental health problems in patients with OA was significantly higher at the age range of 18 to 20 years old (p = 0.002). Also revealed that the greater risk of mental health disorders is in the first months of diagnosis of OA compare to the patients with longer disease duration more than six months (p = 0.01) and patients taking corticosteroids were significantly higher risk of mental health disorders development (p = 0.00).ConclusionIn presented study although the prevalence of OA is higher in group of older people, but psychiatric disorders is more common in OA patients with age range below 20 years. In addition, patients in the early months of OA are at greater risk of psychiatric disorders which the disorders were observed higher in patients taking corticosteroids.

No abstract

A BSTRACT Background: Major depression disorder (MDD) is a mental disorder that affects millions of people worldwide. This disease has negative impacts on quality of life and psychological-related functions. This is a multifactorial disorder; both genetic background and environmental factors have their role. Antidepressants are prescribed as the first line of treatment for patients with depressive disorders. Selective serotonin reuptake inhibitor (SSRI) antidepressants are used to treat MDD and anxiety; however, some patients do not respond to them. Regarding that, magnesium plays a major role in mood regulation; therefore, this study aimed to investigate the role of magnesium supplement in patients with MDD and under an SSRI treatment regimen. Methods: In this randomized, double-blind controlled trial, 60 patients with major depressive disorders based on the DSM-V diagnosis referred to Golestan Hospital in Ahvaz, Iran, were included. The eligible patients were categorized randomly into two thirty-people groups receiving magnesium (intervention) and placebo (control) along with SSRI for 6 weeks. To evaluate the depression status, the Beck II test was applied. Subjects were examined before and after the intervention. Results: There was no statistically significant difference between the two groups in terms of demographic characteristics ( P > 0.05). The mean Beck scores at the beginning of the study and the second week after the intervention were not different between the two groups ( P = 0.97, P = 0.56), whereas the mean Beck scores were lower in the intervention group than in the control group in the fourth and sixth weeks after the intervention ( P = 0.02 and P = 0.001, respectively). Conclusion: Administration of Mg supplement for at least 6 weeks might improve depression symptoms. It can also be considered as a potential adjunct treatment option for MDD patients who are under SSRI treatment.

Introduction: Uterine fibroids are the most common benign tumors in women. Preoperative anxiety is due to concerns about the consequences of surgery and prevents recovery and high prevalence of postoperative pain and increases the length of stay in the hospital. In this study, we tried to investigate the level of anxiety in patients who are candidates for uterine artery embolization (UAE) and myomectomy surgery and its relationship with the length of hospitalization and postoperative pain. Methods: The present descriptive-analytical study was performed on candidates for uterine fibrinoid treatment referred to Ahvaz educational hospitals in 2018. A total of 41 candidates for uterine fibroid treatment were segmented into two groups of 24 candidates for myomectomy surgery and 17 for UAE treatment considering the inclusion and exclusion criteria after informed consent. Data were analyzed by SPSS VER 20 software using Mann–Whitney test, multiple regression, and Chi-square. Results: Myomectomy surgery group recorded more overt and covert anxiety, followed by a longer hospital stay and more postoperative pain ( P < 0.05). The demographic criterion of age was significantly associated with overt and covert anxiety ( P < 0.05). The level of education was significantly associated with overt anxiety ( P < 0.05) and marital status and BMI were not significantly associated with overt and covert anxiety levels ( P > 0.05). Conclusion: According to the results of the study, overt and covert preoperative anxiety in women undergoing myomectomy surgery for symptomatic uterine fibroids is longer than in UAE treatment. And have more pain after surgery.

Introduction: Caesarean section, due to delivery and operating room and anaesthesia as well as well-known complications for the patient, can cause anxiety in patients, and this anxiety creates physical problems for the patient. Aim of the research: To investigate the effects of relaxation therapy on decreasing anxiety in patients with elective caesarean section. Material and methods: This clinical trial was conducted on 90 pregnant women (45 persons in each of two groups), aged 20 to 35 years old, who underwent elective caesarean section in Imam Khomeini Hospital, Ahvaz, Iran during 2016. In the muscle relaxation intervention group, progressive relaxation was performed for 20-25 min. These activities were performed every hour for a total of four times before the surgery. For the control group, neutral contents (e.g. benefits of vegetables and fruits) that were prepared as pamphlets were distributed, and no other intervention was performed. The data were collected using the Hamilton Anxiety Rating Scale (HAM-A). Results: The results showed that explicit anxiety in the intervention group was significantly lower than in the control group, but the groups did not show any significant difference in implicit anxiety. However, relaxation therapy decreased total anxiety in pregnant women prior to caesarean section. Regarding anxiety after caesarean section, the condition was similar, and this technique could decrease implicit anxiety and total anxiety of women. In addition, both groups showed no significant difference between the anxiety pre-and post caesarean section, indicating that the anxiety of women continued after caesarean section. Conclusions: The findings showed that relaxation therapy decreases anxiety levels of pregnant women under caesarean section and can be used to decrease stress and anxiety of mothers. Streszczenie Wprowadzenie: Cesarskie cięcie ze względu na poród, salę operacyjną i znieczulenie oraz dobrze znane powikłania może u pacjentek wywoływać lęk, który wpływa niekorzystnie na ich stan fizyczny. Cel pracy: Zbadanie skutków zastosowania technik relaksacyjnych w zakresie zmniejszania lęku u pacjentek poddanych planowemu cięciu cesarskiemu. Materiał i metody: Badanie kliniczne przeprowadzono u 90 kobiet w ciąży (dwie grupy po 45 osób) w wieku od 20 do 35 lat, które w 2016 r. przeszły planowe cięcie cesarskie w Szpitalu imama Chomejniego w Ahwazie w Iranie. W grupie badanej zastosowano metodę progresywnej relaksacji przez 20-25 minut. Zajęcia przeprowadzano co godzinę, łącznie 4 razy przed operacją. W grupie kontrolnej rozdano broszury zawierające neutralne treści (np. dotyczące korzyści ze spożywania warzyw i owoców) i nie wprowadzono żadnej innej interwencji. Dane zebrano przy użyciu Skali oceny lęku Hamiltona (HAM-A). Wyniki: Stwierdzono, że jawny lęk w grupie badanej był znacznie mniejszy niż w grupie kontrolnej, ale nie wykazano istotnych różnic w zakresie ukrytego lęku. Techniki relaksacyjne zmniejszyły całkowity lęk u kobiet w ciąży przed cięciem cesarskim. W przypadku lęku po cięciu cesarskim...